These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12718717)

  • 1. Chemical genomics as an emerging paradigm for postgenomic drug discovery.
    Salemme FR
    Pharmacogenomics; 2003 May; 4(3):257-67. PubMed ID: 12718717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial informatics in the post-genomics ERA.
    Agrafiotis DK; Lobanov VS; Salemme FR
    Nat Rev Drug Discov; 2002 May; 1(5):337-46. PubMed ID: 12120409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery and development using chemical genomics.
    Sehgal A
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):526-31. PubMed ID: 12197310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era.
    Dougherty TJ; Miller PF
    IDrugs; 2006 Jun; 9(6):420-2. PubMed ID: 16752312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput virtual screening for drug discovery in parallel.
    Toledo-Sherman LM; Chen D
    Curr Opin Drug Discov Devel; 2002 May; 5(3):414-21. PubMed ID: 12058617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational chemogenomics approaches to systematic knowledge-based drug discovery.
    Mestres J
    Curr Opin Drug Discov Devel; 2004 May; 7(3):304-13. PubMed ID: 15216933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular recognition: the fragment approach in lead generation.
    Fattori D
    Drug Discov Today; 2004 Mar; 9(5):229-38. PubMed ID: 14980541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of diversity and focused combinatorial libraries in drug discovery.
    Young SS; Ge N
    Curr Opin Drug Discov Devel; 2004 May; 7(3):318-24. PubMed ID: 15216935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical genomics versus orthodox drug development.
    Szymkowski DE
    Drug Discov Today; 2003 Feb; 8(4):157-9. PubMed ID: 12581708
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemogenomics: drug discovery's panacea?
    Jacoby E
    Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.
    Cancilla MT; He MM; Viswanathan N; Simmons RL; Taylor M; Fung AD; Cao K; Erlanson DA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3978-81. PubMed ID: 18579375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecular therapeutics: emerging strategies for drug discovery in the postgenome era.
    Juliano RL; Astriab-Fisher A; Falke D
    Mol Interv; 2001 Apr; 1(1):40-53. PubMed ID: 14993337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast chemical genomics and drug discovery: an update.
    Hoon S; St Onge RP; Giaever G; Nislow C
    Trends Pharmacol Sci; 2008 Oct; 29(10):499-504. PubMed ID: 18755517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity-oriented synthesis; a spectrum of approaches and results.
    Spandl RJ; Bender A; Spring DR
    Org Biomol Chem; 2008 Apr; 6(7):1149-58. PubMed ID: 18362950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.
    Bieler M; Heilker R; Köppen H; Schneider G
    J Chem Inf Model; 2011 Aug; 51(8):1897-905. PubMed ID: 21761911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in isocyanide based multicomponent reactions in applied chemistry.
    Dömling A
    Chem Rev; 2006 Jan; 106(1):17-89. PubMed ID: 16402771
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.